For citations:
Panevin T.S., Ananyeva L.P. Pathogenetic rationale for prescribing menopausal hormone therapy for systemic sclerosis. Rheumatology Science and Practice. 2022;60(5):538-545. (In Russ.) https://doi.org/10.47360/1995-4484-2022-538-545
Panevin T.S., Ananyeva L.P. Pathogenetic rationale for prescribing menopausal hormone therapy for systemic sclerosis. Rheumatology Science and Practice. 2022;60(5):538-545. (In Russ.) https://doi.org/10.47360/1995-4484-2022-538-545